WA
IONS icon

WPG Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

WPG Advisers’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.26K Hold
70
– – ﹤0.01% 863
2025
Q4 		$5.54K Hold
70
– – ﹤0.01% 876
2025
Q3 		$4.58K Hold
70
– – ﹤0.01% 929
2025
Q2 		$2.77K Buy
+70
New +$2.29K ﹤0.01% 1044

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WPG Advisers's IONS Position: Q1 2026 in Review

WPG Advisers held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 70 shares worth $5.26K. The position accounts for ﹤0.01% of the portfolio, ranked #863.

WPG Advisers first reported a position in IONS in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.54K in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • WPG Advisers held 70 shares of Ionis Pharmaceuticals worth $5.26K as of Q1 2026.
  • WPG Advisers left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of WPG Advisers's portfolio in Q1 2026, its #863 holding.
  • WPG Advisers first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • WPG Advisers's Ionis Pharmaceuticals position peaked at $5.54K in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on WPG Advisers's 13F filing for Q1 2026, filed 30 Apr 2026.